CN1653125A - 白内障和其它眼病发展的改善 - Google Patents
白内障和其它眼病发展的改善 Download PDFInfo
- Publication number
- CN1653125A CN1653125A CNA038112213A CN03811221A CN1653125A CN 1653125 A CN1653125 A CN 1653125A CN A038112213 A CNA038112213 A CN A038112213A CN 03811221 A CN03811221 A CN 03811221A CN 1653125 A CN1653125 A CN 1653125A
- Authority
- CN
- China
- Prior art keywords
- composition
- alkyl
- compound
- combine
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/94—Oxygen atom, e.g. piperidine N-oxide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Description
Tempol-H的浓度 μM | |||
30分钟 | 60分钟 | 120分钟 | |
化合物1 | 51.0 | 20.0 | 1.5 |
30.0 | 30.0 | 1.2 | |
18.0 | 6.0 | 7.0 | |
30.0 | 3.0 | 8.0 | |
平均值 | 32.3 | 14.8 | 4.4 |
μg/ml | (5.5) | (2.5 ) | (0.75) |
Tempol-H的浓度 μM | |||
30分钟 | 90分钟 | 血液 | |
化合物3 | 31.4 | 11.6 | 2.3 |
22.2 | 9.0 | 2.5 | |
平均值 | 26.8 | 10.8 | 2.4 |
μg/ml | (4.6) | (1.9) | (0.4) |
化合物2 | 52.4 | 6.0 | 3.6 |
35.2 | 5.7 | 0.6 | |
平均值 | 43.8 | 5.9 | 2.1 |
μg/ml | (7.5) | (1.0) | (0.4) |
条件 | 溶解性mg/ml | 溶解性%w/v |
水 | 74.9 | 7.5 |
0.9%氯化钠 | 40.5 | 4.1 |
pH值为4.8的0.01M乙酸盐缓冲液 | 68.6 | 6.9 |
pH值为4.8的0.01M柠檬酸盐缓冲液 | 71.1 | 7.1 |
水+1%w/v的甘油 | 62.2 | 6.2 |
水+1%w/v的丙二醇 | 63.8 | 6.4 |
实施例 | IR CKBr)cm-1羰基 | 1H-NMR(270MHz,DMSO-d6)ppm:酯部分 |
57 | 1716 | 3.75(S,9H);6.95(s,2H) |
61 | 17381687 | 2.79(t,2H);3.31(t,2H);7.45(m,2H);7.55(m,1H);7.93(d,2H) |
53 | 1682 | 6.87(d,2H);7.83(d,2H),10.3(br,s,1H) |
51 | 17181755 | 3.9(s,3H),7.18(d,2H),8.07(d,2H0 |
59 | 1723 | 6.54,7.85(dd,J=16.0Hz);6.84(m,1H);7.24(m,1H);7.54(d,1H);7.86(d,1H);10/2(br,s,1H) |
61 | 1718 | 1.96(m,2H);2.30(m,4H);2.78(m,2H) |
49 | 1688 | 2.88(S,6H);6.65(d,2H);7.73(d,2H) |
53 | 1682 | 3.70(s,3H);7.20(d,2H);7.72(d,2H) |
起始物质(结构) | 化学名称 |
Claims (60)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38128702P | 2002-05-17 | 2002-05-17 | |
US60/381,287 | 2002-05-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1653125A true CN1653125A (zh) | 2005-08-10 |
CN100469776C CN100469776C (zh) | 2009-03-18 |
Family
ID=29550095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB038112213A Expired - Fee Related CN100469776C (zh) | 2002-05-17 | 2003-05-19 | 白内障和其它眼病发展的改善 |
Country Status (13)
Country | Link |
---|---|
US (3) | US7442711B2 (zh) |
EP (1) | EP1507826A4 (zh) |
JP (1) | JP4615309B2 (zh) |
KR (1) | KR20060013632A (zh) |
CN (1) | CN100469776C (zh) |
AU (1) | AU2003243282B2 (zh) |
BR (1) | BR0310057A (zh) |
CA (1) | CA2484512C (zh) |
IL (1) | IL164639A (zh) |
MX (1) | MXPA04011416A (zh) |
NO (1) | NO20045483L (zh) |
WO (1) | WO2003096991A2 (zh) |
ZA (1) | ZA200408449B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102584683A (zh) * | 2012-02-29 | 2012-07-18 | 中国人民解放军第四军医大学 | Tempol类衍生物的合成及辐射防护作用 |
CN102746218A (zh) * | 2011-04-21 | 2012-10-24 | 默克专利股份有限公司 | 化合物和液晶介质 |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA04011416A (es) * | 2002-05-17 | 2005-09-30 | Othera Pharmaceuticals Inc | Mejora del desarrollo de las cataratas y otras enfermedades oftalmicas. |
US20040057983A1 (en) | 2002-09-25 | 2004-03-25 | David Schmidt | Biomolecular wearable apparatus |
AU2003300471A1 (en) * | 2003-01-03 | 2004-08-10 | Eric F. Bernstein | Methods for treating ocular diseases |
US7825134B2 (en) * | 2003-05-19 | 2010-11-02 | Othera Holding, Inc. | Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
US7589107B2 (en) * | 2003-05-19 | 2009-09-15 | Othera Holding, Inc. | Amelioration of vitrectomy-induced cataracts |
US20050130906A1 (en) * | 2003-11-20 | 2005-06-16 | Matier William L. | Amelioration of macular degeneration and other ophthalmic diseases |
JP2007527417A (ja) * | 2003-11-20 | 2007-09-27 | オセラ・フアーマシユーチカルズ・インコーポレーテツド | 白内障、黄斑変性および他の眼疾患の改善 |
WO2006127592A2 (en) * | 2005-05-26 | 2006-11-30 | Othera Pharmaceuticals, Inc. | Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts |
US20070197599A1 (en) * | 2006-02-02 | 2007-08-23 | Matier William L | Hydroxylamines and derivatives as anti-angiogenic agents |
US20070203190A1 (en) * | 2006-02-22 | 2007-08-30 | Ghanshyam Patil | Hydroxylamines and derivatives for the inhibition of complement activation |
US20070197593A1 (en) * | 2006-02-22 | 2007-08-23 | Matier William L | Hydroxylamines and derivatives for treatment of inflammatory conditions of the liver |
CA2678363A1 (en) * | 2007-02-16 | 2008-08-21 | Othera Holding, Inc. | Drug resistance reversal in neoplastic disease |
CA2679066A1 (en) * | 2007-02-22 | 2008-08-28 | Othera Holding, Inc. | Hydroxylamine compounds and methods of their use |
EP2217589A4 (en) * | 2007-11-28 | 2012-02-22 | Revision Therapeutics Inc | OCULAR OXIDATIVE STRESS MODULATORS |
US8602961B2 (en) * | 2008-05-15 | 2013-12-10 | Lifewave Products Llc | Apparatus and method of stimulating elevation of glutathione levels in a subject |
JP6071554B2 (ja) | 2009-10-30 | 2017-02-01 | ネステク ソシエテ アノニム | イヌ科動物の眼の健康を維持するため、及び眼の病気を改善するための方法 |
US8778969B2 (en) | 2009-11-07 | 2014-07-15 | Peter H Proctor | Nitrone, nitroso, and nitroxide spintraps and spin labels and their hydroxylamines |
EP2397474A1 (de) * | 2010-06-17 | 2011-12-21 | Construction Research & Technology GmbH | 2-Oxo-1,3-dioxolan-4-carbonsäureester, ihre Herstellung und Verwendung |
US9012647B2 (en) | 2011-04-07 | 2015-04-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders |
MX351799B (es) * | 2011-12-22 | 2017-10-26 | Construction Researcg & Tech Gmbh | 2-oxo-1,3-dioxolan-4-carboxamidas, su preparacion y uso. |
EP2818465A1 (en) * | 2013-06-26 | 2014-12-31 | Construction Research & Technology GmbH | 2-Oxo-1,3-dioxolane-4-acyl halides, their preparation and use |
US9314457B2 (en) | 2014-06-19 | 2016-04-19 | The University Of Utah Research Foundation | Methods of treating and preventing vascular instability diseases |
PL441664A1 (pl) * | 2022-07-07 | 2024-01-08 | Uniwersytet Warszawski | Nitroksylowa pochodna polifenolu, sposoby jej wytwarzania oraz jej zastosowanie |
Family Cites Families (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3936456A (en) | 1972-03-24 | 1976-02-03 | Ciby-Geigy Corporation | Substituted piperazine dione oxyls and hydroxides and polymer compositions stabilized thereby |
US4014335A (en) | 1975-04-21 | 1977-03-29 | Alza Corporation | Ocular drug delivery device |
NL188266C (nl) | 1975-07-29 | 1992-05-18 | Merck & Co Inc | Werkwijze ter bereiding van een oogheelkundig inplantaat. |
US4287175A (en) | 1978-06-22 | 1981-09-01 | Merck & Co., Inc. | Contact lens wetting agents |
JPS5899449A (ja) | 1981-12-09 | 1983-06-13 | Sanyo Chem Ind Ltd | カチオン性ビニルモノマ−の安定化法 |
US4404302A (en) | 1982-05-27 | 1983-09-13 | Ferro Corporation | Acylated hindered hexahydropyrimidines and their use as light stabilizing agents |
US4590231A (en) | 1983-10-11 | 1986-05-20 | Ciba-Geigy Corporation | Polyolefin compositions stabilized against degradation using hydroxylamine derivatives |
AU565354B2 (en) | 1983-11-14 | 1987-09-10 | Bio-Mimetics Inc. | Bioadhesive compositions and methods of treatment therewith |
US4983392A (en) | 1983-11-14 | 1991-01-08 | Bio-Mimetics, Inc. | Bioadhesive compositions and methods of treatment therewith |
US5225196A (en) | 1983-11-14 | 1993-07-06 | Columbia Laboratories, Inc. | Bioadhesive compositions and methods of treatment therewith |
DE3569514D1 (en) | 1984-03-22 | 1989-05-24 | Ciba Geigy Ag | Process for the preparation of nitroxyls of sterically hindered amines |
US4691015A (en) * | 1984-07-23 | 1987-09-01 | Ciba-Geigy Corporation | Hydroxylamines derived from hindered amines |
US5209927A (en) | 1985-01-23 | 1993-05-11 | Alcon Laboratories, Inc. | Ophthalmic solution |
US4668699A (en) | 1985-08-05 | 1987-05-26 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
US4883658A (en) | 1986-04-28 | 1989-11-28 | Holly Frank J | Ophthalmic solution for treatment of dry-eye syndrome |
US4804539A (en) | 1986-07-28 | 1989-02-14 | Liposome Technology, Inc. | Ophthalmic liposomes |
JPS6385547A (ja) | 1986-09-29 | 1988-04-16 | Fuji Photo Film Co Ltd | ハロゲン化銀カラ−写真感光材料 |
US4818537A (en) | 1986-10-21 | 1989-04-04 | Liposome Technology, Inc. | Liposome composition for treating dry eye |
FR2608045B1 (fr) | 1986-12-12 | 1990-03-02 | Chauvin Laboratoires | Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome |
US5278151A (en) | 1987-04-02 | 1994-01-11 | Ocular Research Of Boston, Inc. | Dry eye treatment solution |
US4914088A (en) | 1987-04-02 | 1990-04-03 | Thomas Glonek | Dry eye treatment solution and method |
ES2061723T3 (es) | 1987-09-21 | 1994-12-16 | Ciba Geigy Ag | Estabilizadores n-aciloxi aminicos impedidos. |
DE3851931T2 (de) | 1987-09-21 | 1995-03-16 | Ciba Geigy Ag | Stabilisierung einer Beschichtung mit sterisch gehinderten N-hydroxysubstituierten Aminen. |
DE3801790A1 (de) | 1988-01-22 | 1989-07-27 | Resart Ihm Ag | Kunststoffmaterial mit hoher uv-durchlaessigkeit, verfahren zu dessen herstellung und dessen verwendung |
ATE102666T1 (de) | 1988-06-14 | 1994-03-15 | Ciba Geigy Ag | Verfahren zum fotochemischen stabilisieren von ungefaerbten und gefaerbten polypropylenfasern. |
US5073278A (en) | 1988-07-18 | 1991-12-17 | Ciba-Geigy Corporation | Lubricant composition |
US5004770A (en) | 1988-10-19 | 1991-04-02 | Ciba-Geigy Corporation | Polymeric substrates stabilized with N-substituted hindered amines |
US4927891A (en) | 1988-11-23 | 1990-05-22 | Pennwalt Corporation | Polymer bound light stabilizer coating resins |
US5030243A (en) | 1989-01-05 | 1991-07-09 | Ciba-Geigy Corporation | Process for the photochemical stabilization of undyed and dyeable artificial leather with a sterically hindered amine |
DE4000551A1 (de) | 1989-01-13 | 1990-07-19 | Ciba Geigy Ag | Verfahren zum fotochemischen stabilisieren von gefaerbter wolle |
US5145893A (en) * | 1989-03-21 | 1992-09-08 | Ciba-Geigy Corporation | Non-migrating 1-hydrocarbyloxy hindered amine derivatives as polymer stabilizers |
US5075104A (en) | 1989-03-31 | 1991-12-24 | Alcon Laboratories, Inc. | Ophthalmic carboxy vinyl polymer gel for dry eye syndrome |
JPH0331342A (ja) | 1989-06-28 | 1991-02-12 | Mitsubishi Petrochem Co Ltd | ポリオレフィン樹脂組成物 |
EP0432089B1 (de) | 1989-11-08 | 1996-09-04 | Ciba-Geigy Ag | Schmierstoffzusammensetzungen |
EP0787492B1 (en) | 1990-03-16 | 2003-09-17 | THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE | Use of nitroxides and oxazolidines for protection against ionising radiation and oxidative stress |
EP0459148B1 (en) | 1990-05-29 | 1996-01-03 | Ocular Research Of Boston Inc. | Dry eye treatment composition |
ZA912797B (en) | 1990-05-29 | 1992-12-30 | Boston Ocular Res | Dry eye treatment process and solution |
KR100193146B1 (ko) * | 1990-07-20 | 1999-06-15 | 월터 클리웨인, 한스-피터 위트린 | 안정화된 단량체 조성물 |
US5290888A (en) | 1990-07-20 | 1994-03-01 | Ciba-Geigy Corporation | Process for stabilizing ethylenically unsaturated compounds and stabilized monomer compositions |
EP0467850B1 (en) | 1990-07-20 | 1995-09-06 | Ciba-Geigy Ag | Stabilized monomer compositions |
JPH04166930A (ja) | 1990-10-31 | 1992-06-12 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料 |
US5475013A (en) | 1990-11-19 | 1995-12-12 | Monsanto Company | Retroviral protease inhibitors |
FR2670517B1 (fr) | 1990-12-13 | 1993-04-09 | Normandie Const Meca | Element de franchissement pour le franchissement d'obstacles. |
CA2058823A1 (en) | 1991-01-08 | 1992-07-09 | Rolf Schumacher | Lubricant compositions |
JP2681424B2 (ja) | 1991-04-12 | 1997-11-26 | 富士写真フイルム株式会社 | ハロゲン化銀カラー写真感光材料 |
US5399473A (en) | 1991-04-12 | 1995-03-21 | Fuji Photo Film Company, Ltd. | Silver halide color photographic material |
IT1246779B (it) | 1991-04-12 | 1994-11-26 | Ciba Geigy Spa | Composti piperidinici atti all'impiego come stabilizzanti per materiali organici. |
DK0565487T3 (da) | 1992-04-08 | 1997-05-20 | Ciba Geigy Ag | Flydende antioxidanter som stabilisatorer |
DE4327297B4 (de) | 1992-08-17 | 2007-05-24 | Clariant Finance (Bvi) Ltd. | Verwendung von Piperidinverbindungen |
US5874493A (en) | 1996-04-12 | 1999-02-23 | Clariant Finance (Bvi) Limited | Stabilization of polyolefins |
TW237471B (zh) | 1992-09-03 | 1995-01-01 | Ciba Geigy | |
JPH06172592A (ja) | 1992-12-09 | 1994-06-21 | Sumitomo Chem Co Ltd | カーボンブラック含有ポリオレフィン系樹脂組成物 |
US5707643A (en) | 1993-02-26 | 1998-01-13 | Santen Pharmaceutical Co., Ltd. | Biodegradable scleral plug |
CH688878B5 (de) | 1993-04-06 | 1998-11-13 | Ciba Geigy Ag | Handelsformen von sterisch gehindertem Amin und deren Verwendung. |
IT1270975B (it) | 1993-06-03 | 1997-05-26 | Ciba Geigy Spa | Composti piperidin-triazinici atti all'impiego come stabilizzanti allaluce, al calore e alla ossidazione per materiali organici |
DE4320444A1 (de) | 1993-06-21 | 1994-12-22 | Agfa Gevaert Ag | Farbfotografisches Aufzeichnungsmaterial |
IT1264946B1 (it) | 1993-07-16 | 1996-10-17 | Ciba Geigy Spa | Derivati del 2,2,6,6-tetrametil-4-piperidinolo utili come stabilizzanti alla luce ed all'ossidazione per materiali organici. |
IT1264817B1 (it) | 1993-07-28 | 1996-10-10 | Ciba Geigy Spa | Derivati di polialchil-4-piperidinoli atti all'impderivati di polialchil-4-piperidinoli atti all'impiego come stabilizzanti per materiali organici iego come stabilizzanti per materiali organici |
EP0638616A1 (de) | 1993-08-13 | 1995-02-15 | Ciba-Geigy Ag | Pigmentsalze |
CA2131047A1 (en) | 1993-09-01 | 1995-03-02 | Takashi Sanada | Thermoplastic resin composition |
GB9318846D0 (en) | 1993-09-10 | 1993-10-27 | Sandoz Ltd | Improvements in or relating to organic compounds |
TW327185B (en) | 1993-09-20 | 1998-02-21 | Ciba Sc Holding Ag | Liquid antioxidants |
AU1447095A (en) | 1993-12-30 | 1995-07-17 | Arcturus Pharmaceutical Corporation | Methods for the treatment of the central nervous system or eye involving pathogenic oxidation pathways |
DE59505941D1 (de) | 1994-01-19 | 1999-06-24 | Ciba Geigy Ag | Stabilisieren von Leder gegen thermische und photochemische Zersetzung |
US5466233A (en) | 1994-04-25 | 1995-11-14 | Escalon Ophthalmics, Inc. | Tack for intraocular drug delivery and method for inserting and removing same |
US5981548A (en) | 1994-11-15 | 1999-11-09 | Moreno Paolini | N-Hydroxypiperidines as superoxide radicals scavengers |
US5725493A (en) | 1994-12-12 | 1998-03-10 | Avery; Robert Logan | Intravitreal medicine delivery |
US5518732A (en) | 1995-02-14 | 1996-05-21 | Chiron Vision, Inc. | Bio-erodible ophthalmic shield |
IT1273607B (it) | 1995-04-26 | 1997-07-08 | Ciba Geigy Spa | Combinazione di stabilizzanti per polimeri sintetici organici |
US5699182A (en) | 1995-05-25 | 1997-12-16 | Xytronyx, Inc. | Light fatigue resistant photochromic formulations |
TW416970B (en) | 1995-05-31 | 2001-01-01 | Ciba Sc Holding Ag | Carrier-bound light stabilizers and antioxidants as fillers and stabilizers |
US5718922A (en) | 1995-05-31 | 1998-02-17 | Schepens Eye Research Institute, Inc. | Intravitreal microsphere drug delivery and method of preparation |
US5869079A (en) | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
US6469057B1 (en) * | 1995-06-02 | 2002-10-22 | Mcw Research Foundation, Inc. | Methods for in vivo reduction of free radical levels and compositions useful therefor |
JPH0952975A (ja) | 1995-08-18 | 1997-02-25 | Clariant Internatl Ltd | 顔料の安定化方法及びこの方法に用いる組成物 |
DE19530468A1 (de) | 1995-08-18 | 1997-02-20 | Sandoz Ag | Verwendung von Piperidinverbindungen |
EP0761466B1 (en) | 1995-08-30 | 1999-08-04 | Eastman Kodak Company | Stabilised dye-donor element for use in thermal dye transfer |
US5821374A (en) | 1995-11-21 | 1998-10-13 | Hoffmann-La Roche Inc. | Process for the oxidation of alcohols |
AU1837197A (en) | 1996-01-26 | 1997-08-20 | United States of America, represented by the Secretary, Department of Health and Human Services, The National Institutes of Health, The | Hydroxylamine compositions for the prevention or retardation of cataracts |
GB9607565D0 (en) | 1996-04-12 | 1996-06-12 | Clariant Int Ltd | Stabilizer composition |
DE19618197A1 (de) | 1996-05-07 | 1997-11-13 | Hoechst Ag | Neue sterisch gehinderte Piperidinderivate als Lichtschutzmittel für Polymere |
JPH1045777A (ja) | 1996-07-29 | 1998-02-17 | Sakai Chem Ind Co Ltd | 新規な有機リン化合物及びその用途 |
JPH1045778A (ja) | 1996-07-29 | 1998-02-17 | Sakai Chem Ind Co Ltd | 新規なヒンダードアミン塩及びその用途 |
US6670412B1 (en) | 1996-12-19 | 2003-12-30 | Exxonmobil Chemical Patents Inc. | Method of melt processing amine containing polyethylenes |
WO1998028256A1 (de) | 1996-12-20 | 1998-07-02 | Ciba Specialty Chemicals Holding Inc. | An feste trägermaterialien fixierte umesterungskatalysatoren |
US6194457B1 (en) * | 1997-01-29 | 2001-02-27 | A. Glenn Braswell | Liquid eye drop composition |
US5981584A (en) | 1997-02-06 | 1999-11-09 | Merck & Co., Inc. | Fibrinogen receptor antagonist prodrugs |
JPH10219140A (ja) | 1997-02-07 | 1998-08-18 | Nippon Nsc Ltd | 耐候性塗料用樹脂エマルション |
JPH10220381A (ja) | 1997-02-07 | 1998-08-18 | Matsushita Refrig Co Ltd | 密閉型圧縮機 |
IT1291599B1 (it) | 1997-04-18 | 1999-01-11 | Great Lakes Chemical Italia | Composti appartenenti alla classe delle enammine e loro utilizzo come antiossidanti per polimeri organici |
DE19816681A1 (de) | 1997-04-18 | 1998-10-22 | Ciba Geigy Ag | Azidhaltige Stabilisatoren |
IT1302988B1 (it) | 1997-05-08 | 2000-10-18 | Great Lakes Chemical Italia | Polimeri organici stabilizzati alla luce |
WO1999005108A1 (en) | 1997-07-23 | 1999-02-04 | Ciba Specialty Chemicals Holding Inc. | Inhibition of pulp and paper yellowing using nitroxides and other coadditives |
DE19735255B4 (de) | 1997-08-14 | 2007-08-23 | Clariant Produkte (Deutschland) Gmbh | Synergistisches Stabilisatorgemisch auf Basis von Polyalkyl-1-oxa-diazaspirodecan-Verbindungen und dessen Verwendung |
US5902598A (en) | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
FR2773165B1 (fr) | 1997-12-26 | 2001-06-08 | Rhodia Chimie Sa | Stabilisation des moules en elastomere silicone |
FR2773320B1 (fr) | 1998-01-05 | 2000-03-03 | Optisinvest | Dispositif pour le transfert intraoculaire de produits actifs par iontophorese |
DE19804910A1 (de) | 1998-02-07 | 1999-08-12 | Clariant Gmbh | Polyolefin-Formmasse zur Herstellung von kalandrierten Folien/Platten |
IT1298452B1 (it) | 1998-02-26 | 2000-01-10 | Great Lakes Chemical Italia | Composizioni fotocromatiche dotate di resistenza a fatica alla luce ed articoli fotocromatici che le contengono |
TWI224995B (en) | 1998-03-19 | 2004-12-11 | Ciba Sc Holding Ag | Stabilization of wood substrates |
US6149925A (en) | 1998-11-05 | 2000-11-21 | Color Access, Inc. | Topical compositions for enhancing glutathione production |
US6433007B1 (en) | 1998-12-17 | 2002-08-13 | Alcon Manufacturing, Ltd. | Methods for the prevention and treatment of post-surgical complications |
US6410045B1 (en) | 1999-02-22 | 2002-06-25 | Clyde Lewis Schultz | Drug delivery system for antiglaucomatous medication |
ES2255987T3 (es) | 1999-03-01 | 2006-07-16 | Milcin Therapeutics Llc | Preparaciones oftalmicas conteniendo mucina. |
US6429194B1 (en) | 1999-03-01 | 2002-08-06 | Vista Scientific Llc | Mucin containing ophthalmic preparation |
JP3527435B2 (ja) | 1999-05-21 | 2004-05-17 | ユニ・チャーム株式会社 | 使い捨ておむつ |
TW514581B (en) | 1999-09-02 | 2002-12-21 | Ciba Sc Holding Ag | A method of protecting wood against light-induced degradation by treatment with an impregnation which penetrates the surface of the wood |
US6331313B1 (en) | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
US20010036943A1 (en) | 2000-04-07 | 2001-11-01 | Coe Jotham W. | Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
WO2002000260A1 (fr) | 2000-06-29 | 2002-01-03 | Mitsubishi Pharma Corporation | Jp0105585atif contre des maladies du nerf optique et analogue |
IT1320080B1 (it) | 2000-10-25 | 2003-11-18 | Giuliani Spa | Composizione per uso farmaceutico o dietetico. |
MXPA04010833A (es) * | 2002-05-02 | 2005-02-14 | Ciba Sc Holding Ag | Productos para el cuidado del cuerpo, productos para el hogar, textiles y telas estabilizados. |
MXPA04011416A (es) | 2002-05-17 | 2005-09-30 | Othera Pharmaceuticals Inc | Mejora del desarrollo de las cataratas y otras enfermedades oftalmicas. |
US7825134B2 (en) | 2003-05-19 | 2010-11-02 | Othera Holding, Inc. | Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
JP4288302B1 (ja) | 2008-01-18 | 2009-07-01 | トモデータサービス有限会社 | 位置検出装置および位置検出プログラム並びに施設図面データ |
-
2003
- 2003-05-19 MX MXPA04011416A patent/MXPA04011416A/es active IP Right Grant
- 2003-05-19 KR KR1020047018566A patent/KR20060013632A/ko not_active Application Discontinuation
- 2003-05-19 BR BRPI0310057-0A patent/BR0310057A/pt not_active IP Right Cessation
- 2003-05-19 JP JP2004504990A patent/JP4615309B2/ja not_active Expired - Fee Related
- 2003-05-19 EP EP03753107A patent/EP1507826A4/en not_active Withdrawn
- 2003-05-19 US US10/440,583 patent/US7442711B2/en not_active Expired - Fee Related
- 2003-05-19 AU AU2003243282A patent/AU2003243282B2/en not_active Ceased
- 2003-05-19 WO PCT/US2003/015948 patent/WO2003096991A2/en active Search and Examination
- 2003-05-19 CN CNB038112213A patent/CN100469776C/zh not_active Expired - Fee Related
- 2003-05-19 CA CA2484512A patent/CA2484512C/en not_active Expired - Fee Related
- 2003-05-19 ZA ZA200408449A patent/ZA200408449B/xx unknown
-
2004
- 2004-10-17 IL IL164639A patent/IL164639A/en not_active IP Right Cessation
- 2004-12-16 NO NO20045483A patent/NO20045483L/no not_active Application Discontinuation
-
2008
- 2008-06-18 US US12/141,166 patent/US8383648B2/en not_active Expired - Fee Related
-
2012
- 2012-12-21 US US13/723,586 patent/US20130131052A1/en not_active Abandoned
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102746218A (zh) * | 2011-04-21 | 2012-10-24 | 默克专利股份有限公司 | 化合物和液晶介质 |
US8999460B2 (en) | 2011-04-21 | 2015-04-07 | Merck Patent Gmbh | Compounds and liquid-crystalline medium |
CN102746218B (zh) * | 2011-04-21 | 2017-04-26 | 默克专利股份有限公司 | 化合物和液晶介质 |
US9920248B2 (en) | 2011-04-21 | 2018-03-20 | Merck Patent Gmbh | Compounds and liquid-crystalline medium |
CN102584683A (zh) * | 2012-02-29 | 2012-07-18 | 中国人民解放军第四军医大学 | Tempol类衍生物的合成及辐射防护作用 |
CN102584683B (zh) * | 2012-02-29 | 2014-12-24 | 中国人民解放军第四军医大学 | Tempol类衍生物的合成及辐射防护作用 |
Also Published As
Publication number | Publication date |
---|---|
US8383648B2 (en) | 2013-02-26 |
JP2005527605A (ja) | 2005-09-15 |
US20130131052A1 (en) | 2013-05-23 |
NO20045483L (no) | 2004-12-16 |
IL164639A0 (en) | 2005-12-18 |
ZA200408449B (en) | 2007-09-26 |
CA2484512C (en) | 2013-04-16 |
US20040002461A1 (en) | 2004-01-01 |
MXPA04011416A (es) | 2005-09-30 |
AU2003243282A1 (en) | 2003-12-02 |
EP1507826A4 (en) | 2007-11-07 |
AU2003243282B2 (en) | 2008-05-01 |
CA2484512A1 (en) | 2003-11-27 |
WO2003096991A3 (en) | 2004-02-26 |
JP4615309B2 (ja) | 2011-01-19 |
KR20060013632A (ko) | 2006-02-13 |
EP1507826A2 (en) | 2005-02-23 |
WO2003096991A2 (en) | 2003-11-27 |
US7442711B2 (en) | 2008-10-28 |
BR0310057A (pt) | 2007-04-10 |
US20080274983A1 (en) | 2008-11-06 |
IL164639A (en) | 2012-02-29 |
CN100469776C (zh) | 2009-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1653125A (zh) | 白内障和其它眼病发展的改善 | |
CN1285575C (zh) | 杂环硫代酯和酮 | |
CN1228780A (zh) | 用作基质金属蛋白酶抑制剂的次膦酸酰胺 | |
CN1094614A (zh) | 眼用或鼻用抗过敏组合物 | |
CN1496257A (zh) | 调控免疫球蛋白e及抑制细胞增殖的苯并咪唑化合物 | |
CN1221608A (zh) | Aids抗病毒化合物与hiv抑制剂的协同组合 | |
CN1046727C (zh) | Hiv蛋白酶抑制剂 | |
CN1278178A (zh) | 大环内酯类在治疗癌症和黄斑变性中的应用 | |
CN1151165A (zh) | 三萜衍生物及其药用组合物 | |
KR20070040326A (ko) | 백내장, 황반 변성 및 다른 안과 질환의 개선 | |
CN1291898A (zh) | 用于角膜上皮疾病的药物 | |
JP6509244B2 (ja) | 水晶体硬化抑制剤 | |
CN1674868A (zh) | 包含药物、软膏基质和增溶剂/分散剂的眼用软膏剂组合物 | |
CN1649843A (zh) | 新查耳酮衍生物及其应用 | |
CA3088956A1 (en) | Compositions for preventing or treating uveitis | |
CN1901892A (zh) | 使用ice抑制剂治疗感染疾病 | |
CN1254243C (zh) | 包含白屈菜碱或其衍生物的药物组合物 | |
CN1956955A (zh) | 神经病性疼痛控制剂组合物 | |
WO2018069893A1 (en) | Methods for treating ocular disease using inhibitors of csf-1r | |
CN1481245A (zh) | 用于治疗单纯疱疹病毒的2-氨基苯并噁嗪酮 | |
JPH1135466A (ja) | 白内障予防・治療剤 | |
JPWO2002026229A1 (ja) | 気道粘液分泌抑制剤 | |
JPH10218766A (ja) | 涙液分泌促進および角結膜障害治療剤 | |
CN101052395A (zh) | 用咔唑衍生物治疗增生性皮肤病的方法 | |
ZA200604402B (en) | Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: COLBY PHARMACEUTICAL COMPANY Free format text: FORMER OWNER: OTHERA HOLDINGS INC. Effective date: 20130522 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130522 Address after: American California Patentee after: Colby Pharmaceutical Company Address before: Delaware Patentee before: Othera Holdings Inc. |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090318 Termination date: 20140519 |